Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NBIX
Recent news which mentions NBIX
< Previous
1
2
3
4
5
Next >
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
December 22, 2024
Tickers
BIRK
CHWY
DOCS
DRI
Tags
Briefs
SNY
Stories That Matter
From
Benzinga
What Analysts Are Saying About Neurocrine Biosciences Stock
December 20, 2024
Tickers
NBIX
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential
December 16, 2024
Tickers
CRNX
NBIX
NEWS
Tags
General
CRNX
NBIX
From
Benzinga
Screening For Black Friday Bargains In The Stock Market
December 03, 2024
Tickers
EXPE
NBIX
NVDA
SUPN
Tags
SUPN
NBIX
EXPE
From
Benzinga
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
November 12, 2024
Tickers
ABBV
BMY
NBIX
NEWS
Tags
Reiteration
Equities
Health Care
From
Benzinga
In-Depth Examination Of 20 Analyst Recommendations For Neurocrine Biosciences
October 29, 2024
Tickers
NBIX
Tags
NBIX
Market News
Analyst Ratings
From
Benzinga
Critical Insights From Neurocrine Biosciences Analyst Ratings: What You Need To Know
October 04, 2024
Tickers
NBIX
Tags
NBIX
Benzinga
BZI/AAR
From
Benzinga
"Rule Breaker Investing" Market Cap Game Show: Throwdowns & Long-Term Wins
September 30, 2024
Tickers
AMD
HEI
KFRC
LOW
Tags
LOW
NBIX
SONO
From
Motley Fool
Neurocrine Shifts Focus To New Schizophrenia Treatment After Luvadaxistat Trial Misses Endpoint
September 13, 2024
Tickers
NBIX
NEWS
Tags
Analyst Color
Analyst Ratings
Expert Ideas
From
Benzinga
Decoding 19 Analyst Evaluations For Neurocrine Biosciences
September 09, 2024
Tickers
NBIX
Tags
NBIX
BZI/AAR
Benzinga
From
Benzinga
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
September 08, 2024
Tickers
CRL
DG
GFI
INTC
Tags
DG
PDD
NBIX
From
Benzinga
Dollar General, Temu Parent PDD And Super Micro Computer Are Among Top 10 Large Cap Losers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
September 02, 2024
Tickers
COIN
DG
DLTR
MSTR
Tags
Stories That Matter
Briefs
SYM
From
Benzinga
Why Neurocrine Biosciences Stock Was Tumbling This Week
August 30, 2024
Tickers
NBIX
Tags
Market News
Recent Press Releases
NBIX
From
Motley Fool
Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades Stock
August 29, 2024
Tickers
NBIX
NEWS
Tags
Analyst Color
Market News
Expert Ideas
From
Benzinga
NVIDIA To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Thursday
August 29, 2024
Tickers
CRM
CRWD
EQNR
HPQ
Tags
Trading Ideas
analysts forecasts
Benzinga
From
Benzinga
Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results
August 28, 2024
Tickers
ATPC
AVAV
BOF
FL
Tags
Markets
Mid Day Market Update
FL
From
Benzinga
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
August 28, 2024
Tickers
ABBV
BMY
NBIX
NEWS
Tags
Biotech
Trading Ideas
BMY
From
Benzinga
US Stocks Mixed; JM Smucker Slashes Annual Guidance
August 28, 2024
Tickers
ATPC
BOF
BSLK
NBIX
Tags
Markets
SMCI
Trading Ideas
From
Benzinga
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
August 27, 2024
Tickers
ABBV
BMY
LLY
NBIX
Tags
Stories That Matter
NBIX
M&A
From
Benzinga
Evaluating Neurocrine Biosciences: Insights From 15 Financial Analysts
August 19, 2024
Tickers
NBIX
Tags
NBIX
Analyst Ratings
Market News
From
Benzinga
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Tickers
BPMC
EW
EXAS
IBRX
Tags
Benzinga
EXAS
PFE
From
Benzinga
A Closer Look at 7 Analyst Recommendations For Neurocrine Biosciences
August 01, 2024
Tickers
NBIX
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
July 10, 2024
Tickers
NBIX
Tags
NBIX
BZI/AAR
Benzinga
From
Benzinga
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
Tickers
AMGN
BLUE
BMY
GILD
Tags
BLUE
RARE
Market News
From
InvestorPlace
Key Takeaways From Neurocrine Biosciences Analyst Ratings
May 28, 2024
Tickers
NBIX
Tags
NBIX
Analyst Ratings
Market News
From
Benzinga
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
May 01, 2024
Tickers
NBIX
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
NBIX Stock Earnings: Neurocrine Biosciences Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
Tickers
NBIX
Tags
NASDAQ:NBIX
NBIX
Earnings Reports
From
InvestorPlace
3 Red-Hot Biotech Rockets Blasting Off in 2024
April 24, 2024
Tickers
GERN
NBIX
VKTX
Tags
NASDAQ:VKTX,NASDAQ:GERN,NASDAQ:NBIX
GERN
Stocks to Buy
From
InvestorPlace
Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder
April 23, 2024
Tickers
NBIX
NEWS
TAK
Tags
Trading Ideas
Biotech
Large Cap
From
Benzinga
Where Neurocrine Biosciences Stands With Analysts
April 10, 2024
Tickers
NBIX
Tags
Benzinga
BZI/AAR
Market News
From
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.